Logo

STADA to Acquire GSK's OTC Portfolio for the Expansion of its Consumer Health Business in Europe

Share this

STADA to Acquire GSK's OTC Portfolio for the Expansion of its Consumer Health Business in Europe

Shots:

  • STADA acquires GSK’s six brands containing five skin care/topical application and one pediatric cough remedy namely Oilatum- Eurax- Savlon Antiseptic Cream- Ceridal- Tixylix and Polytar. The transaction is expected to close in Aug 2019
  • The focus of the acquisition is to strengthen and expand STADA’s Consumer Health business in European Healthcare markets. Additionally- the amnufacturing of five skin care products will be transferred to Thornton & Ross (STADA acquired Thornton & Ross) having portfolio and expertise for same
  • Polytar is a coal-tar based dandruff shampoo- marketed as a Tarmed in Spain and Portugal. Eurax is a topical itch relief cream marketed in France- Italy and Norway including UK- Ireland and Hong Kong

Click here to read full press release/ article

Ref: STADA | Image: GSK


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions